Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure
ICU Medical Inc is a medical instruments & supplies business based in the US. ICU Medical shares (ICUI) are listed on the NASDAQ and all prices are listed in US Dollars. ICU Medical employs 15,300 staff and has a trailing 12-month revenue of around $1.8 billion.
Our top pick for
Beginners
Our top pick for
Free trades
Our top pick for
Social traders
| Latest market close | $151.48 |
|---|---|
| 52-week range | $149.87 - $251.77 |
| 50-day moving average | $168.21 |
| 200-day moving average | $198.28 |
| Wall St. target price | $215.00 |
| PE ratio | 351.3637 |
| Dividend yield | $0 (0%) |
| Earnings per share (TTM) | $0.44 |
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Historical closes compared with the close of $151.48 from 2022-09-29
| 1 week (2022-09-23) | -2.02% |
|---|---|
| 1 month (2022-08-30) | -5.23% |
| 3 months (2022-06-30) | -7.85% |
| 6 months (2022-03-30) | -33.30% |
| 1 year (2021-09-30) | -35.09% |
|---|---|
| 2 years (2020-09-30) | -17.12% |
| 3 years (2019-09-30) | 159.6 |
| 5 years (2017-09-29) | 185.85 |
Valuing ICU Medical stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of ICU Medical's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
ICU Medical's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 351x. In other words, ICU Medical shares trade at around 351x recent earnings.
That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.
ICU Medical's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 1.1772. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into ICU Medical's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
ICU Medical's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $216.7 million.
The EBITDA is a measure of a ICU Medical's overall financial performance and is widely used to measure a its profitability.
| Revenue TTM | $1.8 billion |
|---|---|
| Operating margin TTM | 2.9% |
| Gross profit TTM | $491.5 million |
| Return on assets TTM | 1.01% |
| Return on equity TTM | 0.3% |
| Profit margin | 0.31% |
| Book value | $87.28 |
| Market capitalisation | $3.7 billion |
TTM: trailing 12 months
We're not expecting ICU Medical to pay a dividend over the next 12 months.
ICU Medical's shares were split on a 3:2 basis on 17 March 2002. So if you had owned 2 shares the day before before the split, the next day you'd have owned 3 shares. This wouldn't directly have changed the overall worth of your ICU Medical shares – just the quantity. However, indirectly, the new 33.3% lower share price could have impacted the market appetite for ICU Medical shares which in turn could have impacted ICU Medical's share price.
Over the last 12 months, ICU Medical's shares have ranged in value from as little as $149.87 up to $251.77. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while ICU Medical's is 0.5749. This would suggest that ICU Medical's shares are less volatile than average (for this exchange).
ICU Medical, Inc. , together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy and critical care applications worldwide. The company's infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; SwabCap and SwabTip disinfecting caps; Tego hemodialysis connectors; ClearGuard HD, an antimicrobial barrier cap for hemodialysis catheters; and ChemoClave and ChemoLock closed system transfer devices, as well as Diana hazardous drug compounding system for the preparation of hazardous drugs. It also provides IV therapy and diluents, such as sodium chloride, dextrose, balanced electrolyte solutions, lactated ringer's, ringer's, mannitol, sodium chloride/dextrose, and sterile water; and irrigation comprising sodium chloride and sterile water irrigation, physiologic solutions, ringer's irrigation, acetic acid irrigation, glycine irrigation, sorbitol-mannitol irrigation, flexible containers, and pour bottle options. The company offers infusion pumps under the Plum 360 and LifeCare PCA brands; IV mediation safety software, including ICU Medical MedNet, an enterprise-class medication management platform that connects smart pumps to hospital's electronic health records, asset tracking systems, and alarm notification platforms; and related professional services. It also provides critical care products, such as Cogent 2-in-1 and CardioFlo hemodynamic monitoring systems; TDQ and OptiQ cardiac output monitoring catheters; TriOx venous oximetry catheters; Transpac blood pressure transducers; and SafeSet closed blood sampling and conservation systems. The company sells its products to acute care hospitals, wholesalers, ambulatory clinics, and alternate site facilities, including outpatient clinics, home health care providers, and long-term care facilities.
Everything we know about the YanGuFang International Group IPO, plus information on how to buy in.
Looking to invest in tech? Here’s how to buy shares in the major tech companies, known as FAANG stocks.
A simple guide to buying stocks in your favorite European soccer team.
Steps to owning and managing JUVE, with 24-hour and historical pricing before you buy.
Steps to owning and managing ASR, with 24-hour and historical pricing before you buy.
Steps to owning and managing BVB, with 24-hour and historical pricing before you buy.
Everything we know about the Lead Real Estate Co. IPO, plus information on how to buy in.
Everything we know about the Third Harmonic Bio IPO, plus information on how to buy in.
Everything we know about the LINKBANCORP IPO, plus information on how to buy in.
Here are the stocks that benefit from inflation, as well as industries to keep an eye on to reduce the impacts of inflation on your portfolio.